Insider Trading Alert - SGMS, THRX And CAKE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 13, 2014, 182 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $2,715,292,313,281.00.

Highlighted Stocks Traded by Insiders:

Scientific Games (SGMS) - FREE Research Report

Perelman Ronald O, who is Director at Scientific Games, bought 1.1 million shares at $8.97 on May 13, 2014. Following this transaction, the Director owned 33.6 million shares meaning that the stake was reduced by 3.23% with the 1.1 million-share transaction.

Schweinfurth Scott D, who is Executive VP & CFO at Scientific Games, bought 20,000 shares at $9.09 on May 13, 2014. Following this transaction, the Executive VP & CFO owned 20,000 shares meaning that the stake was reduced by 100% with the 20,000-share transaction.

Kennedy David L, who is President and CEO at Scientific Games, bought 36,000 shares at $8.98 on May 13, 2014. Following this transaction, the President and CEO owned 147,534 shares meaning that the stake was reduced by 32.28% with the 36,000-share transaction.

The shares most recently traded at $9.78, up $0.80, or 8.18% since the insider transaction. Historical insider transactions for Scientific Games go as follows:

  • 4-Week # shares sold: 5,904
  • 12-Week # shares sold: 5,904
  • 24-Week # shares sold: 5,904

The average volume for Scientific Games has been 1.4 million shares per day over the past 30 days. Scientific Games has a market cap of $774.3 million and is part of the services sector and leisure industry. Shares are down 42.17% year-to-date as of the close of trading on Tuesday.

Scientific Games Corporation provides technology-based products and services, and associated content for gaming and lottery markets worldwide. The company operates in three segments: Instant Products, Lottery Systems, and Gaming. Currently, there are 5 analysts who rate Scientific Games a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SGMS - FREE

TheStreet Quant Ratings rates Scientific Games as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and generally higher debt management risk. Get the full Scientific Games Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Theravance (THRX) - FREE Research Report

Glaxosmithkline Plc, who is 10% Owner at Theravance, bought 317,770 shares at $8,544,835.30 on May 13, 2014. Following this transaction, the 10% Owner owned 30.6 million shares meaning that the stake was reduced by 1.05% with the 317,770-share transaction.

The shares most recently traded at $28.81, down $8,544,806.49, or 29659168.66% since the insider transaction. Historical insider transactions for Theravance go as follows:

  • 4-Week # shares sold: 35,000
  • 12-Week # shares sold: 35,000
  • 24-Week # shares sold: 35,000

The average volume for Theravance has been 985,300 shares per day over the past 30 days. Theravance has a market cap of $3.0 billion and is part of the health care sector and drugs industry. Shares are down 24.15% year-to-date as of the close of trading on Tuesday.

Theravance, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system/pain. Currently, there are 5 analysts who rate Theravance a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THRX - FREE

TheStreet Quant Ratings rates Theravance as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Theravance Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cheesecake Factory (CAKE) - FREE Research Report

Schmick Douglas L, who is Director at Cheesecake Factory, bought 325 shares at $44.92 on May 13, 2014. Following this transaction, the Director owned 2,510 shares meaning that the stake was reduced by 14.87% with the 325-share transaction.

The shares most recently traded at $44.51, down $0.41, or 0.91% since the insider transaction. Historical insider transactions for Cheesecake Factory go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 3,500
  • 12-Week # shares bought: 1,900
  • 12-Week # shares sold: 3,500
  • 24-Week # shares bought: 1,900
  • 24-Week # shares sold: 3,500

The average volume for Cheesecake Factory has been 703,200 shares per day over the past 30 days. Cheesecake Factory has a market cap of $2.2 billion and is part of the services sector and leisure industry. Shares are down 7.35% year-to-date as of the close of trading on Tuesday.

The Cheesecake Factory Incorporated owns and operates casual dining and full-service restaurants. The stock currently has a dividend yield of 1.25%. The company has a P/E ratio of 21.8. Currently, there are 6 analysts who rate Cheesecake Factory a buy, no analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAKE - FREE

TheStreet Quant Ratings rates Cheesecake Factory as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cheesecake Factory Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Futures Fall on Further Trade Rhetoric from China and 4 Other Stories to Watch

Futures Fall on Further Trade Rhetoric from China and 4 Other Stories to Watch

5 Biggest U.S. Tech Stocks Test $4 Trillion Valuation Amid Bullish Nasdaq Run

5 Biggest U.S. Tech Stocks Test $4 Trillion Valuation Amid Bullish Nasdaq Run

Trade War Fear Creeps Back Into Markets on Thursday

Trade War Fear Creeps Back Into Markets on Thursday